Apollon Jamaica Chairman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Apollon jamaica chairman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Apollon Jamaica Chairman Today - Breaking & Trending Today

Investegate |Apollon Formularies Announcements | Apollon Formularies: Apollon Formulations Kill Prostate Cancer Cells

Apollon Formularies Plc (AQSE: APOL) ( Apollon
or the Company ), a UK based international pharmaceutical company trading on the Aquis Stock Exchange is pleased to announce that its medical cannabis formulations were shown to be effective in killing both hormone-resistant and hormone-sensitive prostate cancer cells in 3D cell cultures in third party independent laboratory testing. ¹ This finding is in addition to the results recently announced on May 18, 2021² that Apollon formulations were successful in killing HER2+ breast cancer cells, and the announcement on June 28, 2021³ that Apollon formulations were successful in killing triple-negative breast cancer cells. This testing was performed under a joint testing agreement with Aion Therapeutic Inc. (CSE: AION) ( Aion ),a BC based international pharmaceutical company trading on the Canadian Securities Exchange. ....

United Kingdom , United States , Herberta Fritsche , Megan Ray , Paul Burke , Tim Blythe , Stephend Barnhill , Stene Jacobs , Apollon Formularies Plc , Aion Therapeutic Inc , Apollon Formularies Jamaica , Directors Of The Company , Md Anderson Cancer Center , Research Development , Ai Pharmaceuticals Jamaica , Laboratory Medicine , Peterhouse Capital , Canadian Securities Exchange , Board Of Aion Therapeutic Inc , Jamaican Cannabis Licensing Authority , Apollon Formularies Jamaica Limited , Cannabis Licensing Authority , Aquis Stock Exchange , Apollon Jamaica Research Development , Formularies Plc , Aion Therapeutic ,

Apollon Formularies (AQSE:APOL) | RNS | Apollon Formularies - Apollon Formulations Kill Prostate Cancer Cells

Apollon Formularies (AQSE:APOL) | RNS | Apollon Formularies - Apollon Formulations Kill Prostate Cancer Cells
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Herberta Fritsche , Megan Ray , Paul Burke , Tim Blythe , Stephend Barnhill , Stene Jacobs , Apollon Formularies Plc , Aion Therapeutic Inc , Apollon Formularies Jamaica , Directors Of The Company , Md Anderson Cancer Center , Research Development , Ai Pharmaceuticals Jamaica , Laboratory Medicine , Peterhouse Capital , Canadian Securities Exchange , Board Of Aion Therapeutic Inc , Jamaican Cannabis Licensing Authority , Apollon Formularies Jamaica Limited , Cannabis Licensing Authority , Aquis Stock Exchange , Apollon Jamaica Research Development , Formularies Plc , Aion Therapeutic ,

Investegate |Apollon Formularies Announcements | Apollon Formularies: Apollon Formulations Kill TNBC Cells

Apollon Formulations Kill Triple-Negative Breast Cancer (TNBC) Cells
Apollon Formularies plc (AQSE: APOL) ( Apollon or the Company ), a UK based international pharmaceutical company trading on Aquis Stock Exchange, is pleased to announce that its proprietary medical cannabis formulations were successful in killing triple-negative breast cancer (TNBC) cells in 3D cell cultures in third party independent laboratory testing. This finding is in addition to the results recently announced on May 18, 2021, that Apollon formulations were successful in killing HER2+ breast cancer cells. This testing was performed under a joint testing agreement with Aion Therapeutic Inc. (CSE: AION) ( Aion ), a BC based international pharmaceutical company trading on the Canadian Securities Exchange. ....

United Kingdom , United States , Richard Pazdur , Herberta Fritsche , Megan Ray , Paul Burke , Tim Blythe , Stephend Barnhill , Stene Jacobs , Aion Therapeutic Inc , Apollon Formularies Jamaica , Directors Of The Company , Oncology Center , Md Anderson Cancer Center , Research Development , Ai Pharmaceuticals Jamaica , Laboratory Medicine , University Of Texas , Canadian Securities Exchange , Board Of Aion Therapeutic Inc , Jamaican Cannabis Licensing Authority , Apollon Formularies Jamaica Limited , Cannabis Licensing Authority , Aquis Stock Exchange , Peterhouse Capital Limited Corporate Adviser , Office Of Oncologic Diseases ,

Apollon Formularies (AQSE:APOL) | RNS | Apollon Formularies - Combined Formulations Kill Breast Cancer Cells

Breast Cancer Cells Through Multiple Pathways

LONDON/TORONTO, Apollon Formularies plc (AQSE: APOL, Apollon or the Company ), a UK based international pharmaceutical company trading on the Aquis Stock Exchange, and Aion Therapeutic Inc. (CSE: AION, Aion ), a BC based international pharmaceutical company trading on the Canadian Securities Exchange, are pleased to announce that joint testing has revealed their combined formulations to be effective in killing HER2+ breast cancer cells grown in 3D cell culture via three separate mechanisms: direct cell cytotoxicity, immune stimulated T-cell cytotoxicity, and macrophage induced phagocytosis. HER2-positive constitutes approximately 20% of all breast cancers.

The testing was performed by BIOENSIS, an independent, pre-clinical predictive pharmaceutical testing laboratory. The medical cannabis formulations were developed by Apollon s affiliate, Apollon Formularies Jamaica Limited ( Apollon Jamaica ), and the medic ....

United States , United Kingdom , City Of , Herberta Fritsche , Graham Simmonds , Trastuzumab Herceptin , Stephend Barnhill , Megan Ray , Paul Burke , Tim Blythe , Stene Jacobs , Aion Therapeutic Inc , Apollon Formularies Jamaica , Doc Place International Inc , Md Anderson Cancer Center , Research Development , Trefis Team , Ai Pharmaceuticals Jamaica , Laboratory Medicine , University Of Texas , Decision Resources Group , Ai Pharmaceutical Limited Pharma , Canadian Securities Exchange , Handbook Of Cannabis Oxford University , Apollon Formularies Jamaica Limited , Cannabis Licensing Authority ,

Combined Apollon and Aion Formulations Kill Breast Cancer Cells [...] | Comunicati stampa CataniaOggi

18 maggio 2021 17:32
Fonte: Adnkronos
#salute-e-benessere
LONDON and TORONTO, May 18, 2021 /PRNewswire/ Apollon Formularies plc (AQSE: APOL) ( Apollon or the Company ), a UK based international pharmaceutical company trading on the Aquis Stock Exchange, and Aion Therapeutic Inc. (CSE: AION) ( Aion ), a BC based international pharmaceutical company trading on the Canadian Securities Exchange, are pleased to announce that joint testing has revealed their combined formulations to be effective in killing HER2+ breast cancer cells grown in 3D cell culture via three separate mechanisms: direct cell cytotoxicity, immune stimulated T-cell cytotoxicity, and macrophage induced phagocytosis. HER2-positive constitutes approximately 20% of all breast cancers.
The testing was performed by BIOENSIS, an independent, pre-clinical predictive pharmaceutical testing laboratory. The medical cannabis formulations were developed by Apollon s affiliate, Apollon Formularies Jamai ....

United States , United Kingdom , City Of , Herberta Fritsche , Graham Simmonds , Trastuzumab Herceptin , Stephend Barnhill , Paul Burke , Megan Ray , Tim Blythe , Stene Jacobs , Ai Pharmaceuticals Jamaica Limited Pharma , Aion Therapeutic Inc , Apollon Formularies Jamaica , Doc Place International Inc , Md Anderson Cancer Center , Research Development , Ai Pharmaceuticals Jamaica , Laboratory Medicine , University Of Texas , Decision Resources Group , Canadian Securities Exchange , Apollon Formularies Jamaica Limited , Cannabis Licensing Authority , Aquis Stock Exchange , Peterhouse Capital Limited Corporate Adviser ,